Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Cardiol Therapeutics Inc (CRDL.TO)

Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders Newsfile - Thu May 29, 6:30AM CDT

Toronto, Ontario--(Newsfile Corp. - May 29, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory...

CRDL.TO : 1.85 (-0.54%)
CRDL : 1.3499 (-1.47%)
Stocks in play: Cardiol Therapeutics Inc. Baystreet - Tue May 27, 8:59AM CDT

Announces that the Company's virtual Annual General Meeting of Shareholders will be webcast on Wednesday, ...

CRDL.TO : 1.85 (-0.54%)
Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT Newsfile - Tue May 27, 6:30AM CDT

Toronto, Ontario--(Newsfile Corp. - May 27, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory...

CRDL.TO : 1.85 (-0.54%)
CRDL : 1.3499 (-1.47%)
Stocks in play: Cardiol Therapeutics Inc. Baystreet - Tue Apr 29, 9:17AM CDT

Today announced that pharmaceutical industry veteran Timothy J. Garnett, M.D., has been nominated to ...

CRDL.TO : 1.85 (-0.54%)
Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors Newsfile - Tue Apr 29, 6:30AM CDT

Former Chief Medical Officer of Eli Lilly brings more than thirty years of pharmaceutical industry experienceToronto, Ontario--(Newsfile Corp. - April 29, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL)...

CRDL.TO : 1.85 (-0.54%)
CRDL : 1.3499 (-1.47%)
Stocks in play: ardiol Therapeutics Inc. Baystreet - Wed Apr 16, 9:53AM CDT

Announced today that Northwestern University has enrolled the first patient in the pivotal Phase III ...

CRDL.TO : 1.85 (-0.54%)
Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis Newsfile - Wed Apr 16, 6:40AM CDT

Designed to assess the impact of CardiolRx™ on preventing episodes of recurrent pericarditis, the first patient has been randomized by Northwestern University in Chicago.Based on a successful end-of-Phase...

CRDL.TO : 1.85 (-0.54%)
CRDL : 1.3499 (-1.47%)
Stocks in play: Cardiol Therapeutics Inc. Baystreet - Tue Apr 1, 8:40AM CDT

Announced today its year-end 2024 update on operations following the filing of its audited Financial ...

CRDL.TO : 1.85 (-0.54%)
Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference Newsfile - Mon Mar 3, 6:42AM CST

Toronto, Ontario--(Newsfile Corp. - March 3, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory...

CRDL.TO : 1.85 (-0.54%)
CRDL : 1.3499 (-1.47%)
Stocks in play: Cardiol Therapeutics Inc. Baystreet - Thu Feb 20, 10:44AM CST

Announced today the publication of research in the Journal of the American College of Cardiology: Basic ...

CRDL.TO : 1.85 (-0.54%)

Barchart Exclusives

Netflix Stock Is Losing Momentum. Can Q2 Earnings Save the Day? Barchart - 59 minutes ago
Netflix stock has lost momentum. The streaming giant is set to release its Q2 earnings next week, but given its stretched valuation, chances are slim that NFLX surges following the report. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot